The multi-center study met its primary endpoint with 53% of CIS ± Ta/T1 patients achieving a complete response (CR) at…
Ferring launches new company FerGene, with a focus on the global development and US commercialization of nadofaragene firadenovec, for high-grade,…
• Ferring will deliver two oral presentations; one showcasing data from MEGASET-HR and the other discussing the influence of body…
A comprehensive analysis of 22,300 non-patient individuals, of which 24.4% had nocturia (defined by the study as ≥2 urinations per…
Parsippany, New Jersey – 14 June 2019 – Rebiotix and Ferring Pharmaceuticals were saddened to learn about the patients mentioned…
Sophie Opdyke will be responsible for building Ferring’s new U.S. oncology division, leading its day-to-day operations, and shaping its long-term…
• Ferring acquired exclusive U.S. commercialization rights for generic Ganirelix Acetate Injection for the prevention of premature ovulation in women…
The INVOcell intravaginal culture (IVC) device uses a woman’s own body as a natural incubator during fertilization and early embryo…
NOCDURNA is the first and only sublingual tablet for the treatment of nocturia due to nocturnal polyuria in adults who…
ZOMA-Jet 10 is a new completely needle-free delivery option available for children and adults being treated with the growth hormone,…